NURS 5334 EXAM 3 (MODULE 7)EXAM
QUESTIONS AND ANSWERS 100%
ACCURATE 2025
, Asthma Treatment Step 1 (Ages 12 and Older) - ANSWERSymptoms driven treatment
with low dose ICS-fomoterol
Asthma Treatment Step 2 (Ages 12 and Older) - ANSWERLow-dose ICS fomorteol as
needed
Or
Daily low-dose maintenance ICS
Asthma Treatment Step 3 (Ages 12 and Older) - ANSWERLow-dose maintenance ICS-
fomoterol
Or
Low-dose ICS and maintenance LABA
Asthma Treatment Step 3 (Ages 12 and Older) - ANSWERMedium dose ICS-formoterol
Or
Medium/high dose ICA and LABA
Asthma Treatment Step 5 (Ages 12 and Older) - ANSWERAdd on LAMA and referral to
a specialist for phenotyping (anti-IgE, anti IL5/5R and IL4R), consider high dose ICS
formiterol
Stepwise approach for managing asthma treatment Step 1 (Ages 6-11) - ANSWERLow
dose ICS taken whenever SABA is taken
What is the MOA of Omalizumab? - ANSWERMonoclonal antibody directed against IgE,
inhibiting the allergic release of inflammatory mediators
What is the MOA of Mepolizumab? - ANSWERMonoclonal antibody against IL-5,
reducing Eosinophil inflammation
Mepolizumab is a sub Q Injection that is for people ages 12 and up, True or False? -
ANSWERTrue
What is the MOA for Benralizumab? - ANSWERMonoclonal antibody against IL-5
receptor, reducing eosinophilic inflammation
Reslizumab and Mepolizumab have the same mechanism of action, what is the
difference in medication administration? - ANSWERReslizumab is IV when
Mepolizumab is Sub Q
What's the MOA of Dupilumab? - ANSWERMonoclonal antibody against IL-4 receptors
QUESTIONS AND ANSWERS 100%
ACCURATE 2025
, Asthma Treatment Step 1 (Ages 12 and Older) - ANSWERSymptoms driven treatment
with low dose ICS-fomoterol
Asthma Treatment Step 2 (Ages 12 and Older) - ANSWERLow-dose ICS fomorteol as
needed
Or
Daily low-dose maintenance ICS
Asthma Treatment Step 3 (Ages 12 and Older) - ANSWERLow-dose maintenance ICS-
fomoterol
Or
Low-dose ICS and maintenance LABA
Asthma Treatment Step 3 (Ages 12 and Older) - ANSWERMedium dose ICS-formoterol
Or
Medium/high dose ICA and LABA
Asthma Treatment Step 5 (Ages 12 and Older) - ANSWERAdd on LAMA and referral to
a specialist for phenotyping (anti-IgE, anti IL5/5R and IL4R), consider high dose ICS
formiterol
Stepwise approach for managing asthma treatment Step 1 (Ages 6-11) - ANSWERLow
dose ICS taken whenever SABA is taken
What is the MOA of Omalizumab? - ANSWERMonoclonal antibody directed against IgE,
inhibiting the allergic release of inflammatory mediators
What is the MOA of Mepolizumab? - ANSWERMonoclonal antibody against IL-5,
reducing Eosinophil inflammation
Mepolizumab is a sub Q Injection that is for people ages 12 and up, True or False? -
ANSWERTrue
What is the MOA for Benralizumab? - ANSWERMonoclonal antibody against IL-5
receptor, reducing eosinophilic inflammation
Reslizumab and Mepolizumab have the same mechanism of action, what is the
difference in medication administration? - ANSWERReslizumab is IV when
Mepolizumab is Sub Q
What's the MOA of Dupilumab? - ANSWERMonoclonal antibody against IL-4 receptors
